Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women

被引:59
作者
Snow, KK
Cote, J
Yang, WN
Davis, NJ
Seddon, JM
机构
[1] Massachusetts Eye & Ear Infirm, Epidemiol Unit, Boston, MA 02114 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA
关键词
D O I
10.1016/S0002-9394(02)01755-5
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: The relationships between reproductive risk factors, including use of hormone replacement therapy and oral contraceptives and severity of age,related maculopathy (ARM) among postmenopausal women were evaluated. We hypothesized that exposure to endogenous or exogenous estrogens would be associated with a reduced risk of advanced ARM. DESIGN. Cross-sectional study. METHODS: The 394 subjects were postmenopausal women with ARM. Logistic regression analysis was used to compare the effects of several reproductive factors across two groups: 193 subjects with nonadvanced ARM and 201 subjects with advanced ARM. RESULTS: Women with ARM who had used postmenopausal estrogen therapy in the past had significantly lower odds of advanced ARM than nonusers, after controlling for other known and potential risk factors (odds ratio [OR] = 0.5, 95% confidence interval [Cl] = 0.30 to 0.98). Older age at menarche was associated with increased odds of advanced ARM (OR = 1.16, 95% CI 1.00 to 1.35). CONCLUSIONS: These findings suggest that exposure to exogenous estrogens may have a beneficial effect of reducing the risk of advanced types of ARM in postmenopausal women with ARM. Few therapeutic or preventive measures currently exist for ARM; therefore, these results deserve further evaluation.
引用
收藏
页码:842 / 848
页数:7
相关论文
共 29 条
  • [1] *AG REL EYE DIS ST, 1992, AG REL EYE DIS STUD
  • [2] PLASMA-LIPOPROTEIN LEVELS AS PREDICTORS OF CARDIOVASCULAR DEATH IN WOMEN
    BASS, KM
    NEWSCHAFFER, CJ
    KLAG, MJ
    BUSH, TL
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (19) : 2209 - 2216
  • [3] CALAF I, 1997, INT J FERTIL WOME S2, V42, P329
  • [5] HORMONAL REPLACEMENT THERAPY AND MORBIDITY AND MORTALITY IN A PROSPECTIVE-STUDY OF POSTMENOPAUSAL WOMEN
    FOLSOM, AR
    MINK, PJ
    SELLERS, TA
    HONG, CP
    ZHENG, W
    POTTER, JD
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1995, 85 (08) : 1128 - 1132
  • [6] ESTROGENS AND MACULAR HOLES - A POSTAL QUESTIONNAIRE
    GRAY, RH
    GREGOR, ZJ
    MARSH, M
    [J]. EYE, 1994, 8 : 368 - 369
  • [7] Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
    Grodstein, F
    Stampfer, MJ
    Manson, JE
    Colditz, GA
    Willett, WC
    Rosner, B
    Speizer, FE
    Hennekens, CH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (07) : 453 - 461
  • [8] Postmenopausal hormone therapy and mortality
    Grodstein, F
    Stampfer, MJ
    Colditz, GA
    Willett, WC
    Manson, JE
    Joffe, M
    Rosner, B
    Fuchs, C
    Hankinson, SE
    Hunter, DJ
    Hennekens, CH
    Speizer, FE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (25) : 1769 - 1775
  • [9] HIRVELA H, 1995, OPHTHALMOLOGY, V102, P108
  • [10] Klein B E, 1994, Trans Am Ophthalmol Soc, V92, P289